Endri M.
- Country
- Italy
- Department
- UOC EMATOLOGIA
Research Overview
- Phase IIA Evaluation of Inotuzumab Ozogamicin Efficacy in Adult B-Cell Acute Lymphoblastic Leukemia with Minimal Residual Disease Pre-Transplantation
- Evaluation of Gemtuzumab Ozogamicin with Chemotherapy on Minimal Residual Disease in Adult Patients with Favorable-Intermediate-Risk Acute Myeloid Leukemia
Data & Insights
Has run more than one trial at 32 of 69 partner sites.
Specializations
Hematologic Oncology
This investigator specializes in treating acute leukemias, with particular focus on both B-cell Lymphoblastic Leukemia and Acute Myeloid Leukemia. Their research interests center on innovative therapeutic approaches for blood-based malignancies.
- B-cell Lymphoblastic Leukemia Treatment
- Acute Myeloid Leukemia Management
- Minimal Residual Disease Assessment
Their work encompasses treatment strategies for adult patients with various forms of leukemia, particularly focusing on pre-transplantation care.
Transplantation Medicine
The investigator's expertise extends to hematopoietic stem cell transplantation procedures and preparatory treatments. They focus on optimizing patient outcomes through targeted therapies before transplantation.
- Pre-transplantation Care
- Disease Status Optimization
- Residual Disease Management
Their research involves developing effective therapeutic strategies for patients preparing for stem cell transplantation.
Targeted Therapies
The investigator works with novel therapeutic agents, including targeted immunotherapies and their combination with standard treatments. Their focus includes studying innovative drug combinations for blood cancers.
- Immunotherapy Applications
- Combination Treatment Strategies
- Treatment Response Assessment
Their research explores the effectiveness of targeted therapies in improving treatment outcomes for acute leukemias.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.